New York Life Investment Management’s Carlyle Group CG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-23,721
Closed -$1.22M 808
2025
Q2
$1.22M Sell
23,721
-1,127
-5% -$48.5K 0.01% 611
2025
Q1
$1.08M Buy
24,848
+586
+2% +$29.1K 0.01% 634
2024
Q4
$1.22M Sell
24,262
-1,165
-5% -$59.1K 0.01% 627
2024
Q3
$1.09M Sell
25,427
-1,127
-4% -$47.3K 0.01% 678
2024
Q2
$1.07M Buy
26,554
+2,413
+10% +$104K 0.01% 666
2024
Q1
$1.13M Buy
24,141
+2,293
+10% +$99.1K 0.01% 643
2023
Q4
$889K Buy
21,848
+393
+2% +$12.9K 0.01% 686
2023
Q3
$647K Buy
21,455
+11,328
+112% +$365K 0.01% 719
2023
Q2
$324K Buy
+10,127
New +$296K ﹤0.01% 1217

Other funds holding CG

New York Life Investment Management's CG Position: Q3 2025 in Review

New York Life Investment Management sold out of Carlyle Group (CG) in Q3 2025, closing a stake of 23,721 shares — an estimated $1.22M sold.

New York Life Investment Management first reported a position in CG in Q2 2023 and held it in 9 quarters. The position peaked at $1.22M in Q4 2024. 638 funds tracked by Wall St. Rank hold CG as of Q3 2025.

  • New York Life Investment Management reported no remaining Carlyle Group position as of Q3 2025 after selling out during the quarter.
  • New York Life Investment Management sold 23,721 Carlyle Group shares in Q3 2025, an estimated $1.22M.
  • New York Life Investment Management first reported a position in Carlyle Group in Q2 2023 and held it in 9 quarters.
  • New York Life Investment Management's Carlyle Group position peaked at $1.22M in Q4 2024.
  • 638 funds tracked by Wall St. Rank held Carlyle Group as of Q3 2025.

Based on New York Life Investment Management's 13F filing for Q3 2025, filed 6 Nov 2025.